CN112661610A - Preparation method of 1, 3-dihydroxy adamantane - Google Patents

Preparation method of 1, 3-dihydroxy adamantane Download PDF

Info

Publication number
CN112661610A
CN112661610A CN202011594934.4A CN202011594934A CN112661610A CN 112661610 A CN112661610 A CN 112661610A CN 202011594934 A CN202011594934 A CN 202011594934A CN 112661610 A CN112661610 A CN 112661610A
Authority
CN
China
Prior art keywords
adamantane
nitroxide
preparation
dihydroxy
cocatalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011594934.4A
Other languages
Chinese (zh)
Other versions
CN112661610B (en
Inventor
蒋小惠
傅志伟
毕景峰
郭颖
贺宝元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Bodong Chemical Technology Co ltd
Original Assignee
Shanghai Bodong Chemical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Bodong Chemical Technology Co ltd filed Critical Shanghai Bodong Chemical Technology Co ltd
Priority to CN202011594934.4A priority Critical patent/CN112661610B/en
Publication of CN112661610A publication Critical patent/CN112661610A/en
Application granted granted Critical
Publication of CN112661610B publication Critical patent/CN112661610B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the technical field of organic synthesis, and discloses a preparation method of 1, 3-dihydroxy adamantane, which comprises the following steps: dissolving adamantane in a solvent, adding a nitroxide free radical catalyst and a cocatalyst, adding hypochlorite under an alkaline condition for oxidation, and purifying to obtain 1, 3-dihydroxy adamantane. The invention has simple synthetic route, and the product yield is high due to the matched use of the nitroxide free radical catalyst and the cocatalyst.

Description

Preparation method of 1, 3-dihydroxy adamantane
Technical Field
The invention relates to the technical field of organic synthesis, in particular to a preparation method of 1, 3-dihydroxy adamantane.
Background
Adamantane alcohol compounds obtained by bonding a hydroxyl group to an adamantane skeleton are very important fine chemical products, and can be used for preparing monomers of photoresists, photochromic compounds, pharmaceutical intermediates and the like, and also have wide applications in the fields of coatings, adhesives, films, adsorbing materials and the like.
As for the preparation method of 1, 3-dihydroxyadamantane, it is known that mainly adamantane is brominated and then hydrolyzed at high temperature under a certain pressure or hydrolyzed using an excessive amount of silver sulfate, and the above method uses an excessive amount of bromine as a resource substance, which is expensive and inconvenient in transportation, resulting in high production cost.
Disclosure of Invention
The technical problem to be solved by the invention is to overcome the defects of the prior art and aim to provide a preparation method for synthesizing 1, 3-dihydroxy adamantane with high yield by a one-step method.
In order to solve the technical problems, the invention provides the following technical scheme:
the invention provides a preparation method of 1, 3-dihydroxy adamantane, which comprises the following steps: dissolving adamantane in a solvent, adding a nitroxide free radical catalyst and a cocatalyst, adding hypochlorite for oxidation, and purifying to obtain 1, 3-dihydroxy adamantane.
The synthetic route is as follows:
Figure BDA0002865608550000011
as a preferred technical scheme of the invention, the nitroxide radical catalyst is piperidine nitroxide radical.
In a preferred embodiment of the present invention, the piperidine nitroxide radical is one of 4-hydroxy-2, 2,6, 6-tetramethylpiperidine-1-oxyl, 4-oxo-2, 2,6, 6-tetramethylpiperidine-1-oxyl and 2,2,6, 6-tetramethylpiperidine-1-oxyl.
As a preferred technical scheme of the invention, the cocatalyst is one of cobalt acetate, nickel acetate and copper acetate.
According to a preferable technical scheme, the molar ratio of the adamantane, the sodium hypochlorite and the nitroxide free radical catalyst is 1 (2-4) to 0.02-0.1, and the molar ratio of the nitroxide free radical catalyst to the cocatalyst is 5 to 1.
Preferably, the molar ratio of adamantane, sodium hypochlorite and nitroxide free radical catalyst is 1:3: 0.05.
As a preferred technical scheme of the invention, the hypochlorite is one of sodium hypochlorite and calcium hypochlorite.
Preferably, the hypochlorite is sodium hypochlorite.
Compared with the prior art, the invention has the following beneficial effects:
(1) the invention has simple synthetic route and small pollution without using bromine-containing compounds.
(2) The nitroxide free radical catalyst and the cocatalyst are used in a matched manner, the metal cocatalyst can promote oxidation, so that 1, 3-dihydroxy adamantane is directly synthesized from adamantane by a one-step method, the molar yield of the product is higher than 79.4%, and the by-products are few.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention. In the drawings:
FIG. 1 is a gas chromatogram of 1, 3-dihydroxyadamantane of example 1;
FIG. 2 is a gas chromatogram of 1, 3-dihydroxyadamantane of example 2;
FIG. 3 is a gas chromatogram of 1, 3-dihydroxyadamantane in example 3.
Detailed Description
The preferred embodiments of the present invention will be described in conjunction with the accompanying drawings, and it will be understood that they are described herein for the purpose of illustration and explanation and not limitation.
Example 1
Figure BDA0002865608550000031
Adamantane (10g,73.4mmol) was dissolved in methylene chloride (100mL) at 0 ℃ and 2,2,6, 6-tetramethylpiperidine-1-oxyl (0.57g,3.65mmol) and cobalt acetate (0.13g,0.73mmol) were added, followed by addition of a 10% by mass sodium hypochlorite solution (111.66g,150mmol), and the reaction solution was stirred for 3 hours. Separating to obtain an organic phase, washing with water, concentrating, adding into ethyl acetate, centrifuging, and filtering for the first time; pulping the solid after the first filtration, centrifuging again, and filtering for the second time; the solid obtained by the second filtration was dried to give 1, 3-dihydroxyadamantane (10.3g,61.2mmol, molar yield 83.4%).
Example 2
Adamantane (10g,73.4mmol) was dissolved in methylene chloride (100mL) at 0 ℃ and 4-hydroxy-2, 2,6, 6-tetramethylpiperidine-1-oxyl (0.63g,3.66mmol) and nickel acetate (0.13g,0.74mmol) were added, followed by addition of a 10% by mass sodium hypochlorite solution (111.66g,150mmol), and the reaction solution was stirred for 3 hours. Separating to obtain an organic phase, washing with water, concentrating, adding into ethyl acetate, centrifuging, and filtering for the first time; pulping the solid after the first filtration, centrifuging again, and filtering for the second time; the solid obtained by the second filtration was dried to give 1, 3-dihydroxyadamantane (10g,59.4mmol, molar yield 81.0%).
Example 3
Adamantane (10g,73.4mmol) was dissolved in methylene chloride (100mL) at 0 ℃ and 4-oxo-2, 2,6, 6-tetramethylpiperidine-1-oxyl (0.63g,3.70mmol) and copper acetate (0.15g,0.75mmol) were added, and a 10% sodium hypochlorite solution (111.66g,150mmol) was added to stir the reaction solution for 3 hours. Separating to obtain an organic phase, washing with water, concentrating, adding into ethyl acetate, centrifuging, and filtering for the first time; pulping the solid after the first filtration, centrifuging again, and filtering for the second time; the solid obtained by the second filtration was dried to give 1, 3-dihydroxyadamantane (9.8g,58.3mmol, molar yield 79.4%).
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (6)

1. A preparation method of 1, 3-dihydroxy adamantane is characterized by comprising the following steps: dissolving adamantane in a solvent, adding a nitroxide free radical catalyst and a cocatalyst, adding hypochlorite for oxidation, and purifying to obtain 1, 3-dihydroxy adamantane.
2. The method of claim 1, 3-dihydroxyadamantane preparation according to claim 1, where the nitroxide catalyst is piperidine nitroxide.
3. The method of claim 2, wherein the piperidine nitroxide radical is one of 4-hydroxy-2, 2,6, 6-tetramethylpiperidine-1-oxyl, 4-oxo-2, 2,6, 6-tetramethylpiperidine-1-oxyl, and 2,2,6, 6-tetramethylpiperidine-1-oxyl.
4. The method of claim 1, 3-dihydroxyadamantane preparation according to claim 1, characterised in that the promoter is one of cobalt acetate, nickel acetate and copper acetate.
5. A method for preparing 1, 3-dihydroxy adamantane according to any of claims 1 to 4, characterized in that the molar ratio of adamantane, sodium hypochlorite and nitroxide catalyst is 1 (2-4): 0.02-0.1, and the molar ratio of nitroxide catalyst and cocatalyst is 5: 1.
6. The method of claim 1, 3-dihydroxyadamantane preparation, wherein the hypochlorite is one of sodium hypochlorite and calcium hypochlorite.
CN202011594934.4A 2020-12-28 2020-12-28 Preparation method of 1, 3-dihydroxy adamantane Active CN112661610B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011594934.4A CN112661610B (en) 2020-12-28 2020-12-28 Preparation method of 1, 3-dihydroxy adamantane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011594934.4A CN112661610B (en) 2020-12-28 2020-12-28 Preparation method of 1, 3-dihydroxy adamantane

Publications (2)

Publication Number Publication Date
CN112661610A true CN112661610A (en) 2021-04-16
CN112661610B CN112661610B (en) 2022-09-02

Family

ID=75411948

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011594934.4A Active CN112661610B (en) 2020-12-28 2020-12-28 Preparation method of 1, 3-dihydroxy adamantane

Country Status (1)

Country Link
CN (1) CN112661610B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981420A (en) * 1997-02-17 1999-11-09 Daicel Chemical Industries, Ltd. Oxidation catalytic system and oxidation process
JP2004051497A (en) * 2002-07-17 2004-02-19 Mitsubishi Gas Chem Co Inc Method for producing adamantanediols
JP2005306802A (en) * 2004-04-23 2005-11-04 Mitsubishi Gas Chem Co Inc Method for producing adamantanediol
JP2010265210A (en) * 2009-05-14 2010-11-25 Mitsubishi Gas Chemical Co Inc Method for producing adamantanols
CN104725194A (en) * 2015-02-03 2015-06-24 泸州大洲化工有限公司 Preparation method of adamantanol compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981420A (en) * 1997-02-17 1999-11-09 Daicel Chemical Industries, Ltd. Oxidation catalytic system and oxidation process
JP2004051497A (en) * 2002-07-17 2004-02-19 Mitsubishi Gas Chem Co Inc Method for producing adamantanediols
JP2005306802A (en) * 2004-04-23 2005-11-04 Mitsubishi Gas Chem Co Inc Method for producing adamantanediol
JP2010265210A (en) * 2009-05-14 2010-11-25 Mitsubishi Gas Chemical Co Inc Method for producing adamantanols
CN104725194A (en) * 2015-02-03 2015-06-24 泸州大洲化工有限公司 Preparation method of adamantanol compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NOBUHIRO ISHITO,等: "Ruthenium-Immobilized Periodic Mesoporous Organosilica:Synthesis, Characterization, and Catalytic Application for Selective Oxidation of Alkanes", 《CHEM. EUR. J. 》 *
NORITAKA MIZUNO,等: "Oxidative functional group transformations with hydrogen peroxide catalyzed by a divanadium-substituted phosphotungstate", 《CATALYSIS TODAY》 *

Also Published As

Publication number Publication date
CN112661610B (en) 2022-09-02

Similar Documents

Publication Publication Date Title
CN111704555B (en) Method for synthesizing 4-methoxy-2-nitroaniline by adopting continuous flow reactor
CN105646632A (en) Method for preparing 7-dehydrogenized cholesteryl ester from 7-tosylhydrazones-3-cholesteryl ester
CN112661610B (en) Preparation method of 1, 3-dihydroxy adamantane
CN114507240A (en) Preparation method of cyclobutane tetracarboxylic dianhydride
JP2013517266A (en) Process for producing 4-aminomethylbenzoic acid
CN111320545A (en) Microchannel reaction process of p \ m-nitrobenzaldehyde
JP2904038B2 (en) Process for producing 4,6-diaminoresorcinol and its precursor
AU2021107114A4 (en) Method for preparing epalrestat
WO2020010765A1 (en) Method for synthesizing terbutaline intermediate
CN108276261A (en) Catalytic molecular oxygen aoxidizes the method for preparing 2- bromine Fluorenones in a kind of water phase
CN109651234B (en) Synthesis method of donepezil hydrochloride
CN112707858B (en) Preparation method for synthesizing polymerization inhibitor 702 by using acetone and ammonia gas as raw materials through one-pot method
CN111848423B (en) Preparation method of tert-butyl 3-oxocyclobutylcarbamate
CN110938015B (en) Preparation method of azido-substituted salicylic acid derivative
CN117209394A (en) Preparation method of diacetone acrylamide
CN113698341B (en) Pyridine purification method
CN115819232B (en) Synthesis method of cycloalkyl acrylate compound
CN116768785A (en) Synthesis method of spirofluorene-containing indole derivative structure
CN117964456A (en) Method for preparing (+/-) -4,7,12,15-and (+/-) -4,5,15,16-tetrabromo [2,2] p-cycloaralkyl
CN113336645A (en) Method for synthesizing p-acetoxystyrene by one-pot method
CN117736073A (en) Synthesis method of 9, 9-bis (3-phenyl-4-hydroxyphenyl) fluorene
CN114315583A (en) Preparation method and device of acrylate compound
CN115108896A (en) Efficient preparation method of 2-adamantanone
CN117736072A (en) Synthesis method of 9, 9-bis (4-hydroxy-3-methylphenyl) fluorene
CN114805015A (en) Synthesis process of 2, 4-dichloro-9, 9-dimethyl-9H-fluorene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant